4:15-4:30 P.M.

Assessing Clinical Utility with Real-World Evidence

Greg Rossi

Vice President, Payer and Real-World Evidence

AstraZeneca UK

4:30--5:15 P.M.

Discussion with Speakers and Participants on Paths Forward

5:15-5:30 P.M.

FINAL REMARKS

5:15-5:30 P.M.

Concluding Remarks

Robert McCormack, Workshop Co-Chair

Head of Technology Innovation and Strategy

Veridex, LLC

5:30 P.M.

ADJOURN



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement